Trial Profile
A Phase 2 Study of LY2196044 Compared With Placebo in the Treatment of Alcohol Dependence.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Odelepran (Primary)
- Indications Alcohol withdrawal
- Focus Proof of concept; Therapeutic Use
- Sponsors Eli Lilly and Company
- 09 May 2014 New trial record